SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nectar Lifesciences informs about closure of trading window

27 Jun 2025 Evaluate

With reference to the Company’s earlier communication No. NLL/CS/2025/-471 dated March 26, 2025, on ‘Closure of Trading Window’ effective April 1, 2025, in terms of the Code of Conduct as per Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015. In this regard, Nectar Lifesciences has informed that the trading window for dealing in securities of the Company shall continue to remain closed for the designated persons and their immediate relatives till the declaration of audited financial results of the Company for the quarter and year ended March 31, 2025 as well as from July 01, 2025, till 48 hours after the declaration of unaudited financial results for quarter ended June 30, 2025. The date of the Board Meeting of the Company for declaration of audited financial results of the Company for the quarter and year ended March 31, 2025, and/or unaudited financial results for quarter ended June 30, 2025, will be intimated in due course. Accordingly, Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

12.14 0.16 (1.34%)
05-Jun-2026 11:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.00
Dr. Reddys Lab 1277.05
Cipla 1388.10
Zydus Lifesciences 1089.75
Lupin 2272.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×